Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Sana Blotechnology Inc. is active in the Biotechnology & Pharmaceuticals technology area. The portfolio currently features 1 pending office action, which represents the total active workload for the company at the patent office. This indicates a focused period of prosecution for their current biological or pharmaceutical claims. The presence of a single active matter suggests a targeted approach to securing their intellectual property rights.
The portfolio is being reviewed by 1 distinct examiner and is situated within 1 distinct art unit. Such a narrow focus suggests that the intellectual property being sought is highly specialized. The involvement of only one art unit means that the prosecution strategy does not need to account for the varying standards of different patent office divisions, centralizing all legal efforts within one technical domain.
VIJAYARAGHAVAN, JAGAMYA NMN is the busiest examiner for this portfolio, with 1 busiest examiner pending action. As this is the only pending action in the portfolio, this examiner holds a central role in the company current patenting process. The prosecution outcome for the company active biotechnology filings rests entirely on the interactions with this specific examiner, as indicated by the busiest examiner pending count of 1.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VIJAYARAGHAVAN, JAGAMYA NMN | 1 | 61.9% | +51.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17639843 | CD24-ASSOCIATED PARTICLES AND RELATED METHODS AND USES THEREOF | VIJAYARAGHAVAN, JAGAMYA NMN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17639843 | CD24-ASSOCIATED PARTICLES AND RELATED METHODS AND USES THEREOF | VIJAYARAGHAVAN, JAGAMYA NMN | — |
| Art Unit | Apps |
|---|---|
| 1633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17639843 | CD24-ASSOCIATED PARTICLES AND RELATED METHODS AND USES THEREOF | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | §103§112 | Final Rejection | — | Pending | Mar 02, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSana Blotechnology Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Jagamya Nmn Vijayaraghavan has the most, with 1 of Sana Blotechnology Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.